Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
ME Bahar, HJ Kim, DR Kim - Signal transduction and targeted therapy, 2023 - nature.com
Metastatic dissemination of solid tumors, a leading cause of cancer-related mortality,
underscores the urgent need for enhanced insights into the molecular and cellular …
underscores the urgent need for enhanced insights into the molecular and cellular …
The BCL2 family: key mediators of the apoptotic response to targeted anticancer therapeutics
The ability of cancer cells to suppress apoptosis is critical for carcinogenesis. The BCL2
family proteins comprise the sentinel network that regulates the mitochondrial or intrinsic …
family proteins comprise the sentinel network that regulates the mitochondrial or intrinsic …
Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors
MN Serasinghe, SY Wieder, TT Renault, R Elkholi… - Molecular cell, 2015 - cell.com
Mitochondrial division is essential for mitosis and metazoan development, but a mechanistic
role in cancer biology remains unknown. Here, we examine the direct effects of oncogenic …
role in cancer biology remains unknown. Here, we examine the direct effects of oncogenic …
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
EF Lee, TJ Harris, S Tran, M Evangelista… - Cell death & …, 2019 - nature.com
Malignant melanoma is one of the most difficult cancers to treat due to its resistance to
chemotherapy. Despite recent successes with BRAF inhibitors and immune checkpoint …
chemotherapy. Despite recent successes with BRAF inhibitors and immune checkpoint …
Inhibition of anti-apoptotic Bcl-2 proteins in preclinical and clinical studies: current overview in cancer
S D'Aguanno, D Del Bufalo - Cells, 2020 - mdpi.com
The dynamic interplay between pro-death and pro-survival Bcl-2 family proteins is
responsible for a cell's fate. Due to the recognized relevance of this family in cancer …
responsible for a cell's fate. Due to the recognized relevance of this family in cancer …
Physiological and pharmacological control of BAK, BAX, and beyond
MPA Luna-Vargas, JE Chipuk - Trends in cell biology, 2016 - cell.com
Cellular commitment to the mitochondrial pathway of apoptosis is accomplished when
proapoptotic B cell chronic lymphocytic leukemia/lymphoma (BCL)-2 proteins compromise …
proapoptotic B cell chronic lymphocytic leukemia/lymphoma (BCL)-2 proteins compromise …
Bcl-2 family inhibitors sensitize human cancer models to therapy
E Valentini, M Di Martile, M Brignone, M Di Caprio… - Cell Death & …, 2023 - nature.com
BH3 mimetics, targeting the Bcl-2 family anti-apoptotic proteins, represent a promising
therapeutic opportunity in cancers. ABT-199, the first specific Bcl-2 inhibitor, was approved …
therapeutic opportunity in cancers. ABT-199, the first specific Bcl-2 inhibitor, was approved …
Melatonin enhances autophagy and reduces apoptosis to promote locomotor recovery in spinal cord injury via the PI3K/AKT/mTOR signaling pathway
Y Li, Y Guo, Y Fan, H Tian, K Li, X Mei - Neurochemical research, 2019 - Springer
Spinal cord injury (SCI) leads to neuronal death resulting in central nervous system (CNS)
dysfunction; however, the pathogenesis is still poorly understood. Melatonin (MT), a …
dysfunction; however, the pathogenesis is still poorly understood. Melatonin (MT), a …
MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway
J Zhang, Y Shi, D Hong, M Song, D Huang, C Wang… - Scientific reports, 2015 - nature.com
Accumulating evidences indicate that microRNAs play a vital role in regulating tumor
progression. However, the roles of miR-148b in hepatocellular carcinoma (HCC) are still …
progression. However, the roles of miR-148b in hepatocellular carcinoma (HCC) are still …
Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment
AM Lucianò, M Di Martile, AB Pérez-Oliva… - Journal of Experimental …, 2023 - Springer
Background Macrophages take center stage in the tumor microenvironment, a niche
composed of extracellular matrix and a heterogeneous group of cells, including immune …
composed of extracellular matrix and a heterogeneous group of cells, including immune …